Jazz Pharmaceuticals plc
JAZZ· Nasdaq
Released Aug 5, 2025, after the close
10-Q filed Aug 6, 2025, 37 days after period end · 0001232524-25-000063
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $1.05B | $1.02B | $957.32M | $932.88M |
| Net Income | -$718.50M | $168.57M | $104.44M | $34.67M |
| EPS Diluted |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| -$11.74 |
| $2.49 |
| $1.52 |
| $0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.